ASX IPOs: NexSen debuts amid surging small caps, $8 million raise fully subscribed
NexSen raises $8 million at 20 cents to develop rapid diagnostics. Lead manager Alpine gets options at 30 cents. Clinical trials start Q4.
Tue 14 Oct 25, 10:53am (AEST)